Engineering proteases with altered specificity
Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzy...
Gespeichert in:
Veröffentlicht in: | Current opinion in biotechnology 1994, Vol.5 (4), p.403-408 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 408 |
---|---|
container_issue | 4 |
container_start_page | 403 |
container_title | Current opinion in biotechnology |
container_volume | 5 |
creator | Leis, Jonathan P Cameron, Craig E |
description | Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected
in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities. |
doi_str_mv | 10.1016/0958-1669(94)90049-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16571753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0958166994900493</els_id><sourcerecordid>16571753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</originalsourceid><addsrcrecordid>eNp9kDtPwzAQxy0EKqXwDUDKhGBIOceveEFCVXlIlVhgthznUozSpNgpqN-ehFYdmW74P-7uR8glhSkFKu9AizylUuobzW81ANcpOyJjmiudAs_0MRkfLKfkLMZPABBMwYiMlJKCKjYm03mz9A1i8M0yWYe2QxsxJj---0hs3WHAMolrdL7yznfbc3JS2TrixX5OyPvj_G32nC5en15mD4vUMaa7FDNuyww4VkJJkErw3IHKuSh0UXB0nIqKodRlxquSV2h1hVpRh8yCEpCxCbne9fYnfW0wdmblo8O6tg22m2ioFIoqwXoj3xldaGMMWJl18CsbtoaCGTCZgYEZGBjNzR8mM8Su9v2bYoXlIbTn0uv3Ox37J789BhOdx8Zh6QO6zpSt_3_BL2kkdk0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16571753</pqid></control><display><type>article</type><title>Engineering proteases with altered specificity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Leis, Jonathan P ; Cameron, Craig E</creator><creatorcontrib>Leis, Jonathan P ; Cameron, Craig E</creatorcontrib><description>Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected
in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.</description><identifier>ISSN: 0958-1669</identifier><identifier>EISSN: 1879-0429</identifier><identifier>DOI: 10.1016/0958-1669(94)90049-3</identifier><identifier>PMID: 7765173</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aspartic Acid Endopeptidases - genetics ; Aspartic Acid Endopeptidases - metabolism ; Bacteria - enzymology ; human immunodeficiency virus 1 ; Models, Molecular ; Mutagenesis ; Protein Engineering ; Retroviridae - enzymology ; Rous sarcoma virus ; Serine Endopeptidases - genetics ; Serine Endopeptidases - metabolism ; Structure-Activity Relationship ; Substrate Specificity</subject><ispartof>Current opinion in biotechnology, 1994, Vol.5 (4), p.403-408</ispartof><rights>1994</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</citedby><cites>FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0958166994900493$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7765173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leis, Jonathan P</creatorcontrib><creatorcontrib>Cameron, Craig E</creatorcontrib><title>Engineering proteases with altered specificity</title><title>Current opinion in biotechnology</title><addtitle>Curr Opin Biotechnol</addtitle><description>Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected
in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.</description><subject>Aspartic Acid Endopeptidases - genetics</subject><subject>Aspartic Acid Endopeptidases - metabolism</subject><subject>Bacteria - enzymology</subject><subject>human immunodeficiency virus 1</subject><subject>Models, Molecular</subject><subject>Mutagenesis</subject><subject>Protein Engineering</subject><subject>Retroviridae - enzymology</subject><subject>Rous sarcoma virus</subject><subject>Serine Endopeptidases - genetics</subject><subject>Serine Endopeptidases - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Substrate Specificity</subject><issn>0958-1669</issn><issn>1879-0429</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtPwzAQxy0EKqXwDUDKhGBIOceveEFCVXlIlVhgthznUozSpNgpqN-ehFYdmW74P-7uR8glhSkFKu9AizylUuobzW81ANcpOyJjmiudAs_0MRkfLKfkLMZPABBMwYiMlJKCKjYm03mz9A1i8M0yWYe2QxsxJj---0hs3WHAMolrdL7yznfbc3JS2TrixX5OyPvj_G32nC5en15mD4vUMaa7FDNuyww4VkJJkErw3IHKuSh0UXB0nIqKodRlxquSV2h1hVpRh8yCEpCxCbne9fYnfW0wdmblo8O6tg22m2ioFIoqwXoj3xldaGMMWJl18CsbtoaCGTCZgYEZGBjNzR8mM8Su9v2bYoXlIbTn0uv3Ox37J789BhOdx8Zh6QO6zpSt_3_BL2kkdk0</recordid><startdate>1994</startdate><enddate>1994</enddate><creator>Leis, Jonathan P</creator><creator>Cameron, Craig E</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>1994</creationdate><title>Engineering proteases with altered specificity</title><author>Leis, Jonathan P ; Cameron, Craig E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-e24ad204ef576067548c07845b9bb4ec415f3e69d24fd4fea9fe971ce3a075023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Aspartic Acid Endopeptidases - genetics</topic><topic>Aspartic Acid Endopeptidases - metabolism</topic><topic>Bacteria - enzymology</topic><topic>human immunodeficiency virus 1</topic><topic>Models, Molecular</topic><topic>Mutagenesis</topic><topic>Protein Engineering</topic><topic>Retroviridae - enzymology</topic><topic>Rous sarcoma virus</topic><topic>Serine Endopeptidases - genetics</topic><topic>Serine Endopeptidases - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Substrate Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leis, Jonathan P</creatorcontrib><creatorcontrib>Cameron, Craig E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Current opinion in biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leis, Jonathan P</au><au>Cameron, Craig E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineering proteases with altered specificity</atitle><jtitle>Current opinion in biotechnology</jtitle><addtitle>Curr Opin Biotechnol</addtitle><date>1994</date><risdate>1994</risdate><volume>5</volume><issue>4</issue><spage>403</spage><epage>408</epage><pages>403-408</pages><issn>0958-1669</issn><eissn>1879-0429</eissn><abstract>Recent analysis of the crystal structures, both of the retroviral aspartyl proteases from Rous sarcoma virus and human immunodeficiency virus type 1 and of the serine proteases subtilisin and α-lytic protease, has enabled the rational design of mutations in the substrate-binding pocket of these enzymes. Alterations in steady-state kinetic properties of the purified mutant enzymes have been detected
in vitro by following the cleavage of synthetic peptide substrates. These analyses have identified key amino acid residues in each of these enzymes that are involved in substrate specificity, and they have provided the foundation for the design of proteases with novel substrate specificities.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>7765173</pmid><doi>10.1016/0958-1669(94)90049-3</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0958-1669 |
ispartof | Current opinion in biotechnology, 1994, Vol.5 (4), p.403-408 |
issn | 0958-1669 1879-0429 |
language | eng |
recordid | cdi_proquest_miscellaneous_16571753 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aspartic Acid Endopeptidases - genetics Aspartic Acid Endopeptidases - metabolism Bacteria - enzymology human immunodeficiency virus 1 Models, Molecular Mutagenesis Protein Engineering Retroviridae - enzymology Rous sarcoma virus Serine Endopeptidases - genetics Serine Endopeptidases - metabolism Structure-Activity Relationship Substrate Specificity |
title | Engineering proteases with altered specificity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A56%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineering%20proteases%20with%20altered%20specificity&rft.jtitle=Current%20opinion%20in%20biotechnology&rft.au=Leis,%20Jonathan%20P&rft.date=1994&rft.volume=5&rft.issue=4&rft.spage=403&rft.epage=408&rft.pages=403-408&rft.issn=0958-1669&rft.eissn=1879-0429&rft_id=info:doi/10.1016/0958-1669(94)90049-3&rft_dat=%3Cproquest_cross%3E16571753%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16571753&rft_id=info:pmid/7765173&rft_els_id=0958166994900493&rfr_iscdi=true |